StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) stock

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.32−0.14 (-1.65%)

Close on Nov 18, 2026Market cap $799.08MP/E 11.7Yield –

MeiraGTx operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

MeiraGTx's operating income for the twelve months ending Jun 30, 2026 was $184.03M. For fiscal 2025 it was -$105.97M. The highest annual figure on record is -$31.68M in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$105.97M–
FY2024Dec 31, 2024-$164.21M–
FY2023Dec 31, 2023-$137.06M–
FY2022Dec 31, 2022-$116.36M–
FY2021Dec 31, 2021-$72.76M–
FY2020Dec 31, 2020-$62.55M–
FY2019Dec 31, 2019-$58.27M–
FY2018Dec 31, 2018-$78.10M–
FY2017Dec 31, 2017-$31.68M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$244.43M–
Q1 FY2026Mar 31, 2026-$40.82M–
Q4 FY2025Dec 31, 2025$26.47M–
Q3 FY2025Sep 30, 2025-$46.05M–
Q2 FY2025Jun 30, 2025-$44.79M–
Q1 FY2025Mar 31, 2025-$41.60M–
Q4 FY2024Dec 31, 2024-$31.49M–
Q3 FY2024Sep 30, 2024-$40.04M–
Q2 FY2024Jun 30, 2024-$45.91M–
Q1 FY2024Mar 31, 2024-$46.77M–
Q4 FY2023Dec 31, 2023-$43.75M–
Q3 FY2023Sep 30, 2023-$32.76M–
Q2 FY2023Jun 30, 2023-$28.79M–
Q1 FY2023Mar 31, 2023-$31.76M–
Q4 FY2022Dec 31, 2022-$41.06M–
Q3 FY2022Sep 30, 2022-$22.81M–
Q2 FY2022Jun 30, 2022-$23.76M–
Q1 FY2022Mar 31, 2022-$28.73M–
Q4 FY2021Dec 31, 2021-$7.69M–
Q3 FY2021Sep 30, 2021-$22.55M–
Q2 FY2021Jun 30, 2021-$20.48M–
Q1 FY2021Mar 31, 2021-$22.03M–
Q4 FY2020Dec 31, 2020-$13.22M–
Q3 FY2020Sep 30, 2020-$8.43M–
Q2 FY2020Jun 30, 2020-$25.23M–
Q1 FY2020Mar 31, 2020-$15.68M–
Q4 FY2019Dec 31, 2019-$5.44M–
Q3 FY2019Sep 30, 2019-$10.91M–
Q2 FY2019Jun 30, 2019-$21.23M–
Q1 FY2019Mar 31, 2019-$20.69M–
Q4 FY2018Dec 31, 2018-$20.15M–
Q3 FY2018Sep 30, 2018-$14.74M–
Q2 FY2018Jun 30, 2018-$25.17M–
Q1 FY2018Mar 31, 2018-$18.05M–
Q4 FY2017Dec 31, 2017-$8.36M–
Q3 FY2017Sep 30, 2017-$8.76M–
Q2 FY2017Jun 30, 2017-$7.59M–

More MeiraGTx figures

See a number that looks wrong?